Direct fibrinogen assay

Chemistry: analytical and immunological testing – Optical result

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

422 8209, 435 13, G01N 2100, G01N 2175

Patent

active

052234371

ABSTRACT:
An endpoint assay for measuring fibrinogen utilizing strong thrombin and weak plasma. In a preferred embodiment the assay is based on the direct conversion of a normalized signal from a sensor to fibrinogen concentration.

REFERENCES:
patent: 3658480 (1972-04-01), Kane et al.
patent: 3833864 (1974-09-01), Kiess et al.
patent: 3861877 (1975-01-01), Matharani et al.
patent: 3989382 (1976-11-01), Kent et al.
patent: 4659550 (1987-04-01), Schildknecht
patent: 4720787 (1988-01-01), Lipscomb
Brown, Hematology:, Principles and Procedures, Third Edition, 1982 by Lea & Febiger, Pa., pp. 15-16.
Henry et al., Clinical Chemistry, Principles and Technics, Bio-Science Laboratory, Second Edition, 1974 by Harper and Row, N.Y., pp. 453-455-460.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Direct fibrinogen assay does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Direct fibrinogen assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Direct fibrinogen assay will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1754867

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.